StemCell Therapy

More On This Industry Summary News Leaders & Laggards Company Index Industry Browser Related Industries Diagnostic Substances Drug Delivery Drug Manufacturers - Major Drug Manufacturers - Other Drug Related Products Drugs - Generic Top Industries Auto Manufacturers - Major Biotechnology Business Software & Services Chemicals - Major Diversified Communication Equipment Conglomerates Diversified Computer Systems Diversified Investments Diversified Utilities Drug Manufacturers - Major Electric Utilities Food - Major Diversified Industrial Metals & Minerals Major Airlines Major Integrated Oil & Gas Money Center Banks Property & Casualty Insurance Semiconductor - Broad Line Telecom Services - Domestic Tobacco Products, Other Complete Industry List... In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report. Industry Market Summary Biotechnology Composite Value:918.9 Today's Change:-0.68% S&P 500: -0.29% Biotechnology News Stemline Therapeutics SL-401 Phase 2 BPDCN Data Delivered Via Oral Presentation at ASCO; High Response Rates Demonstrated Across All Lines As Enrollment Proceeds Sat 7:07 pm ET (GlobeNewswire) NEW YORK, June 04, 2016-- Stemline Therapeutics, Inc. announced today the oral presentation of positive clinical data from its ongoing SL-401 Phase 2 potentially pivotal clinical trial in blastic plasmacytoid ... TESARO Provides Pipeline Update at ASCO Investor Briefing - (GlobeNewswire) Data Presented at ASCO 2016 Builds upon Foundation of Abraxane Plus Gemcitabine as a First-Line Treatment in Patients with Metastatic Pancreatic Cancer - (Business Wire) More News on Biotechnology: Latest News, Industry Top Performers Intraday Price Performance % Change Market Cap More Top Intraday Price Performers... Market Capitalization % Change Market Cap SHIRE [SHP.L] -0.94% $2607.6 B AMGEN [AMGN.MX] -0.52% $2216.5 B GILEAD SCIENCES [GILD.MX] -0.62% $2134.9 B SUN PHARMACEUTICALS INDUSTRIES [SUNPHARMA.NS] -1.26% $1831.4 B AMGEN-T [4332.HK] 0.00% $505.0 B More Top Companies by Market Cap... More Top Performers: by Valuation, by Growth, by Financial Strength Industry Calendar Upcoming Events Date Co Event 06/05/16 EXEL Exelixis Inc Investor/Analyst Briefing to Review Cabozantinib Data at the American Society of Clinical Oncology (ASCO) Annual Meeting 06/06/16 ARIA ARIAD Pharmaceuticals Investor and Analyst Briefing and Webcast 06/11/16 AGIO Agios Pharmaceuticals Inc Conference Call to Discuss Data from PKR Activators AG-348 and AG-519 More Upcoming Events... Recent Events Date Co Event 06/03/16 BLUE bluebird bio, Inc. coverage initiated by Cantor Fitzgerald 06/03/16 OMER Omeros Corporation coverage initiated by Cantor Fitzgerald 06/03/16 ONCE Spark Therapeutics, Inc. coverage initiated by Cantor Fitzgerald More Recent Events... Locate Industry by Company Enter Symbol: AdChoices Industry Statistics Market Capitalization: 9,619B Price / Earnings: 165.8 Price / Book: 23.4 Net Profit Margin (mrq): 19.7% Price To Free Cash Flow (mrq): -290.2 Return on Equity: 15.4% Total Debt / Equity: 105.0 Dividend Yield: 2.0% View Industry Browser Community Spotlight Most Active Boards Board Popularity CTRX PGLAF NRPH Unusually Active Boards Board Variance CTRX NRPH PDLI RSS Feeds

Add headlines to your personalized My Yahoo Page ( About My Yahoo and RSS )

View post:
Biotechnology Overview: Industry Center - Yahoo Finance

This entry was posted on August 4, 2016 at 9:36 am and is filed under Biotechnology. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |